Thromb Haemost 2000; 84(03): 410-412
DOI: 10.1055/s-0037-1614036
Schattauer GmbH

A Comparison of INRs Determined with a Whole Blood Prothrombin Time Device and two International Reference Preparations for Thromboplastin

A. M. H. P. van den Besselar
1   From the Haemostasis and Thrombosis Research Centre, Leiden University Medical Centre, Leiden, The Netherlands
› Author Affiliations
Excellent technical assistance was provided by J. Meeuwisse-Braun, C. van Rijn, H. Schaefer-van Mansfeld, and E. Witteveen. The staff of the Leiden Thrombosis Service assisted in the recruitment of patients on long-term oral anticoagulant therapy. Roche Diagnostics provided the CoaguChek PT system and financial support to perform this study. International reference preparations for thromboplastin were provided by the WHO laboratory at Amsterdam, The Netherlands. The critical reading of the draft manuscript by Dr. W. Plesch is greatly appreciated.
Further Information

Publication History

Received 24 November 1999

Accepted after resubmission 17 April 2000

Publication Date:
14 December 2017 (online)


Oral anticoagulant therapy is usually monitored with the prothrombin time (PT) on citrate plasma samples. In recent years instruments have been developed for measurement of the PT in non-citrated whole blood. In the present study, the manufacturer’s calibration of one type of device (CoaguChek®) in terms of the international normalized ratio (INR) was evaluated by one laboratory. Three subsequent lots of test strips for the CoaguChek were investigated using blood samples from 56 coumarin-treated patients. Citrated plasma samples from the same patients were analysed with two international reference preparations for thromboplastin (IRP), i. e., rTF/95 (recombinant human) and RBT/90 (rabbit brain). There were statistically significant INR differences between CoaguChek and the international reference preparations (p <0.001), but the mean relative deviation of the INR was not greater than 0.104. Clinically relevant criteria were used to assess the agreement between the CoaguChek and the IRP results. Standard agreement ranged from 82% to 95%. It is concluded that these test strips achieved a clinically acceptable level of accuracy. Further studies of patient management with these strips are justified.